Cross-border team advises on international CRO transaction

Global law firm Norton Rose Fulbright has advised Heads Group (Heads) on its sale to Veeda Group (Veeda).

Heads is a full-service global contract research organization (CRO) specializing in conducting clinical trials in haemato-oncology and having corporate and operational presence in 25 multiple locations across Europe, North America and the Asia Pacific region. Veeda is an independent, full-service CRO headquartered in Ahmedabad, India with a strong record of bioequivalence studies and early and late phase clinical trials.

The transaction sees the sellers receive cash and equity in Veeda, as well as an earnout. With this complex transaction, Veeda acquired a complete range of clinical trial services, from Phase I to IV.

The cross-border Norton Rose Fulbright team advising on this transaction was led by partner Elena Tsohou assisted by senior associate Nikos Anagnostopoulos in Athens, and also included partners James Parker, Dominic Stuttaford, Holly Stebbing and James Dunnett, senior associates Oliver Kabongo, Nonna Crane and India Furse, associate Elisabeth Trotter, counsel Sunny Wong and Fiona Bundy-Clarke in London, senior counsel Jay Modrall and associate Angelos Vlazakis in Brussels, and partner Attilio Pavone and associate Federico Moriconi in Milan. The firm’s Athens, London, Brussels and Milan teams worked in collaboration with teams from Walkers (Ireland) LLP in Dublin, Ireland, and Trilegal in Mumbai, India.